Novavax Long Term Deferred Assets (Quarterly) Insights

Novavax, Inc. (NVAX)

8.01 +0.23 (+2.96%) USD | NASDAQ | Jan 16, 16:00

7.98 -0.03 (-0.37%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for NVAX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Moderna, Inc.	Upgrade
Merck & Co., Inc.	--
ANI Pharmaceuticals, Inc.	Upgrade
Arcturus Therapeutics Holdings, Inc.	--